Legis Daily

DXM Abuse Prevention Act of 2019

USA116th CongressHR-863| House 
| Updated: 1/30/2019
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (3)
Ron Kind (Democratic)Yvette D. Clarke (Democratic)Bill Johnson (Republican)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
DXM Abuse Prevention Act of 2019 This bill addresses the sale and distribution of dextromethorphan (DXM). Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer. The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 30, 2019
Introduced in House
Jan 30, 2019
Referred to the House Committee on Energy and Commerce.
  • January 30, 2019
    Introduced in House
  • January 30, 2019
    Referred to the House Committee on Energy and Commerce.

Health

Child healthCivil actions and liabilityDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesLicensing and registrationsPrescription drugsRetail and wholesale trades

DXM Abuse Prevention Act of 2019

USA116th CongressHR-863| House 
| Updated: 1/30/2019
DXM Abuse Prevention Act of 2019 This bill addresses the sale and distribution of dextromethorphan (DXM). Specifically, the bill requires a retailer that sells certain drugs containing DXM to have a verification system that is intended to ensure that no one under 18 years of age purchases such drugs from the retailer. The bill also establishes restrictions on (1) the sale of over-the-counter drugs containing DXM, and (2) the distribution of bulk DXM.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jan 30, 2019
Introduced in House
Jan 30, 2019
Referred to the House Committee on Energy and Commerce.
  • January 30, 2019
    Introduced in House
  • January 30, 2019
    Referred to the House Committee on Energy and Commerce.
Doris O. Matsui

Doris O. Matsui

Democratic Representative

California

Cosponsors (3)
Ron Kind (Democratic)Yvette D. Clarke (Democratic)Bill Johnson (Republican)

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Child healthCivil actions and liabilityDrug, alcohol, tobacco useDrug safety, medical device, and laboratory regulationDrug trafficking and controlled substancesLicensing and registrationsPrescription drugsRetail and wholesale trades